JPMorgan Chase & Co. Issues Pessimistic Forecast for Victrex (LON:VCT) Stock Price

Victrex (LON:VCT) had its price target lowered by analysts at JPMorgan Chase & Co. from GBX 725 to GBX 625 in a research note issued on Wednesday,London Stock Exchange reports. The brokerage presently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 10.98% from the stock’s current price.

Separately, Deutsche Bank Aktiengesellschaft lowered their price objective on Victrex from GBX 850 to GBX 780 and set a “hold” rating on the stock in a research report on Tuesday, December 2nd. One analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of GBX 756.25.

Victrex Price Performance

LON:VCT traded down GBX 37.81 during mid-day trading on Wednesday, hitting GBX 563.19. 275,360 shares of the stock traded hands, compared to its average volume of 994,554. The business’s 50-day moving average price is GBX 681.06 and its 200 day moving average price is GBX 670.08. The company has a quick ratio of 1.99, a current ratio of 3.01 and a debt-to-equity ratio of 11.30. The company has a market cap of £490.39 million, a PE ratio of 17.71, a price-to-earnings-growth ratio of 1.92 and a beta of 0.65. Victrex has a 12-month low of GBX 561 and a 12-month high of GBX 999.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.